manufacturer
-
Generic drug manufacturers forge alliances in face of tough economic climate
The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public and private health payers keen to control costs. But in the current economic climate, downward pressure on prices is impacting the generic sector, with increases in acquisition and strategic partnering now firmly part of the competitive landscape.
manufacturer | 28 February 2012
-
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases (NTDs). Averaging 1.4 billion treatments annually, the donations build upon companies’ existing medicines donation programs which already reach millions of people around the world.
manufacturer | 09 February 2012
-
APEC endorses principles for industry codes of ethics
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) welcomes the decision taken at the Asia-Pacific Economic Cooperation CEO Summit to endorse “The Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector”, often referred to as the “Mexico City Principles”. These principles are fully aligned with the IFPMA’s global Code of Pharmaceutical Marketing Practices which sets standards for ethical promotion of medicines. The IFPMA looks forward to the Mexico City Principles being adopted by all industry sectors on a voluntary basis within all 21 APEC countries.
manufacturer | 16 November 2011
-
Code reading ability a priority for manufacturers
Cognex offers a comprehensive range of 1D barcode and 2D Data Matrix code reading tools. Its patented IDMax technology allows for an accurate read of every type of code regardless of the size, quality, printing method or surface the codes are marked…
manufacturer | 12 July 2010
-
Qiagen Acquires DxS
Qiagen has acquired DxS, a privately-held developer and manufacturer of companion diagnostic products headquartered in Manchester, UK. The transaction is valued at approximately US$95 million in cash, plus up to an additional US$35 million if specifi…
manufacturer | 09 October 2009
-
A Paradigm Shift in Vaccine Production
Subunit vaccines that do not require cold chain support and which can be produced quickly in large quantities, may be an attractive option for less-capital intensive drug manufacturers in Asia.
manufacturer | 01 August 2009
-
API Manufacturing: Complying with International GMP Regulations
Asian Manufacturers of Active Pharmaceutical Ingredients (API) have to adhere to Good Manufacturing Practice (GMP) guidelines in order to penetrate Western markets.
manufacturer | 01 June 2009
-
ChemWerth Partners with Steroid API Manufacturer
ChemWerth has announced a manufacturing partnership with Tianjin Tianyao Pharmaceuticals, a manufacturer of corticosteroid products in Asia. Located in Tianjin, China, the latter holds the chairmanship of the Chinese state steroid hormone association…
manufacturer | 25 May 2009
-
What technologies and/or practices can Asian pharma manufacturers adopt today, to ensure quality in their products?
Implementation of an effective inspection and controlling system. The implementation of a quality management system is one aspect, while the appropriate control of it, is just another chapter towards a fully-grown and developed GMP system for qu…
manufacturer | 14 May 2009
-
Blue Inspection Body Audits API Manufacturers in China And India
Audit service provider, blue inspection body will be conducting third-party audits of excipient and active pharmaceutical ingredient (API) manufacturers in Asia at the beginning of March. The company, accredited for this purpose, is offering ma…
manufacturer | 02 March 2009
